In vivo CT detection of lipid-rich coronary artery atherosclerotic plaques using quantitative histogram analysis: a head to head comparison with IVUS.

BACKGROUND: Coronary atherosclerotic plaque characterisation may contribute to risk stratification for future cardiovascular events. The ability of computed tomography to classify plaques as 'fibrous' or 'lipid-rich' based on their average CT attenuation has been investigated but is fraught with substantial limitations. In this study, we evaluated the potential of analysing the distribution of CT attenuation values measured in Hounsfield Units (HU) within coronary atherosclerotic plaques to classify non-calcified plaques into fibrous and lipid-rich subtypes. Intravascular ultrasound (IVUS) served as the gold standard. PATIENTS AND METHODS: We evaluated the data sets of 40 patients (30 males, 59±10 years) who had been referred for invasive coronary angiography for clinical reasons and in whom IVUS was performed in at least one coronary vessel. Using dual source CT, coronary CT angiography was performed as a part of a research protocol within 24 h previous to invasive coronary angiography. A contrast-enhanced volume dataset was acquired with retrospective ECG gating (120 kV, 400 mAs/rot, collimation 2 mm×64 mm×0.6 mm, 60-80 ml contrast agent i.v). IVUS was performed using a 40-MHz IVUS catheter (Atlantis, Boston Scientific Corporation, Natick, MA) and motorized pullback at 0.5 mm/s. Fifty five corresponding non-calcified plaques within the coronary artery system were identified in both DSCT and IVUS using bifurcation points as fiducial markers. In DSCT data sets, serial parallel cross-sections (1mm slice thickness) were rendered orthogonally to the centre line of the coronary artery for each of the 55 plaques. For each cross section and each plaque, a histogram of CT attenuation values (increments of 10HU) was determined. The percentage of pixels with a density ≤30 HU was calculated. Using IVUS as the gold standard, plaques were classified as predominantly fibrous (hyperechoic) or predominantly lipid-rich (hypoechoic). RESULTS: 15 predominantly fibrous plaques vs. 40 predominantly lipid-rich plaques were identified in IVUS. The mean CT attenuation in both plaque types was significantly different (67±31 HU vs. 96±40 HU, p=0.006), yet with a wide overlap. For the 15 fibrous plaques identified in IVUS, the mean percentage of pixels ≤30 HU in CT was 6±10%. For lipid-rich plaques it was 16±10% (p<0.0001). ROC curve analysis revealed that a cut-off of 5.5% pixels with an attenuation ≤30 HU identified lipid rich plaques in CT angiography with a sensitivity of 95% (38/40, 95% CI 83-99) and a specificity of 80% (12/15, 95% CI 52-96) [AUC 0.9, 95% CI 0.7-1.0]. Using this threshold, the negative predictive value was 86% (12/14, 95% CI 57-98) and the positive predictive value was 93% (38/41, 95% CI 80-98). CONCLUSION: Lipid-rich coronary atherosclerotic plaques contain a significantly higher percentage of pixels with low CT attenuation as compared to fibrous plaques. Histogram analysis may help to differentiate both plaque types. A cut-off of 5.5% of pixels with an attenuation of ≤30 HU allowed identification of lipid-rich plaques with a sensitivity of 95% and a specificity of 80%.

Percutaneous mitral valvotomy versus closed surgical commissurotomy. Up to 15 years of follow-up of a prospective randomized study.

BACKGROUND: Immediate and intermediate term results of percutaneous mitral valvotomy (PMV) are comparable to closed surgical commissurotomy (CSC). We aimed at exploring this relation in the long term. METHODS: Previously, we randomized 40 consecutive patients with moderate to severe mitral stenosis [defined as mitral valve area (MVA) less than 1.5 cm²] to undergo either PMV (PMV group = 20 patients) or CSC (CSC group = 20 patients). For all patients, full echocardiographic assessment was performed before the procedure/operation. Patients assigned to PMV underwent the double balloon technique. Echocardiographic assessment was done following both procedures before discharge and repeated 1 and 6 months later. Echocardiographic follow-up was performed, thereafter, on a yearly basis for up to 15 years, with a mean follow-up period of 99 ± 12 months. RESULTS: Immediate echocardiographic results showed no statistically significant difference between the 2 groups regarding the final MVA or mean diastolic gradient across the mitral valve. Two patients dropped out from the CSC group and one from the PMV group. MVA was 1.8 ± 0.3 cm² versus 1.8 ± 0.4 cm² (p > 0.05) and mean diastolic pressure gradient across the mitral valve was 7 ± 4 mmHg versus 6.6 ± 4 mmHg (p > 0.05) in the PMV and CSC groups, respectively. Mitral restenosis occurred in 5 (26.3%) patients in the PMV group versus 5 (27.8%) patients in the CSC group (p > 0.05). Kaplan-Meier curves for restenosis-free survival showed no difference between the 2 groups. CONCLUSION: PMV achieves comparable results to CSC both in the short and long term.

Combined cutting balloon angioplasty and intracoronary beta radiation for treatment of in-stent restenosis: clinical outcomes and effect of pullback radiation for long lesions.

Intracoronary beta (beta) radiation decreases the incidence of target lesion revascularization after percutaneous intervention (PCI) for in-stent restenosis (ISR). Cutting balloon (CB) angioplasty may also be superior to other percutaneous techniques for the treatment of ISR. We sought to study the outcomes of patients with ISR who underwent both CB angioplasty and intracoronay beta radiation and compare them to patients with ISR who underwent other PCI techniques without concomitant radiation. We also sought to evaluate the safety and efficacy of pullback intracoronary beta radiation for the treatment of long ISR lesions. Between January 2001 and November 2001, 102 patients (mean age = 55 +/- 13 years) with ISR underwent both CB angioplasty and intracoronay beta radiation. beta radiation was delivered using the Beta Cath (Novoste) 30 mm system, and pullback radiation was performed in 41 patients. A comparison group included a total of 393 patients with ISR who underwent other PCI techniques without concomitant intracoronary radiation therapy. Follow-up was obtained in 99 patients (97%) in the CB angioplasty with intracoronary radiation group and 377 patients (96%) in the comparison group. At follow-up, both target vessel revascularization (TVR) and major adverse cardiovascular events (MACE) occurred significantly less in the CB angioplasty with intracoronary radiation group than in the comparison group (7% vs. 18% for TVR, and 14% vs. 24% for MACE; P < 0.05 for both). In the pullback radiation group, TVR was performed in five patients (12%), and MACE occurred in eight patients (20%). A combination of CB angioplasty and intracoronay beta radiation for ISR seems to yield low rates of subsequent target vessel revascularization and adverse cardiac events. In addition, pullback beta radiation using the Beta Cath (Novoste) 30 mm system is safe and can be used to treat long ISR lesions effectively. Further randomized trials are needed to confirm these findings.